This is a less severe form of Niemann-Pick Disease that usually appears later in childhood or adulthood. It causes fats to build up mainly in the liver and spleen. It does not usually affect the brain, but it can cause liver problems.
Every report comes from a Lived member, sent anonymously.
Have you tried Enzyme Replacement Therapy for Niemann-Pick Disease Type B?
Niemann-Pick disease type B is a rare inherited condition in which the body cannot properly break down a fatty substance called sphingomyelin. The fat builds up inside cells, mainly in the spleen, liver and lungs. The most common early sign is an enlarged spleen, often with an enlarged liver, and many people later develop lung involvement that can cause shortness of breath. Other common features include low platelet counts that lead to easy bruising or nosebleeds, an unhealthy cholesterol pattern, thinner bones and, in children, slower growth. Type B is the milder, chronic form of a disorder now called acid sphingomyelinase deficiency (ASMD). Unlike type A, which begins in infancy and severely affects the brain, type B usually involves the body's organs with little or no effect on the brain, and most people live into adulthood. Severity varies widely: some people are diagnosed as young children with serious liver or lung disease, while others are found as adults with mild, stable disease. Despite the similar name, Niemann-Pick disease type C is a separate condition with a different cause.
Type B is caused by changes (variants) in both copies of the SMPD1 gene, which carries the instructions for an enzyme called acid sphingomyelinase. This enzyme normally breaks down sphingomyelin inside cells. When too little of it works, sphingomyelin accumulates and gradually damages the organs where it collects. The condition is inherited in an autosomal recessive pattern, meaning a person must inherit a nonworking copy of the gene from each parent. Parents who each carry one copy usually have no symptoms, and each of their children has a one-in-four chance of being affected. Nothing a person does causes the disease or sets it off. Once the family's gene variants are known, brothers, sisters and other at-risk relatives can be tested, since some people with type B have few symptoms for years.
Because it is rare and varies so much, type B is often recognized late. An enlarged spleen or liver, a low platelet count, a lung scan showing scarring-like changes and an unusual cholesterol pattern can each have many causes, but together they should prompt testing. Some adults first undergo a bone marrow biopsy to look for blood cancer before the real cause is found. The key test measures acid sphingomyelinase activity in white blood cells from a blood sample (or occasionally in skin cells grown in a lab). Very low activity confirms the diagnosis. Genetic testing for SMPD1 variants supports the result and helps with family testing. A blood marker called lyso-sphingomyelin is usually markedly raised and is also used to track the disease. The enzyme test cannot reliably predict whether someone will develop nerve or brain problems, so a careful neurological examination is part of the assessment. Doctors also measure the size of the spleen and liver (often with MRI or ultrasound), test lung function and check blood counts, liver tests and cholesterol to set a baseline.
There is currently no cure, but type B is treatable. Care works best through a specialist metabolic center coordinating with liver, lung and blood specialists. Olipudase alfa (Xenpozyme) is an enzyme replacement therapy: a lab-made version of the missing enzyme, given as an intravenous (IV) infusion every two weeks after a gradual dose increase. It is approved by the US Food and Drug Administration (FDA) for adults and children to treat the parts of the disease outside the brain and nervous system. In a year-long placebo-controlled trial in adults, the spleen shrank by about 39 percent more than with placebo and lung function measures improved, along with smaller liver size and higher platelet counts. Children treated in studies also grew better. It does not treat or prevent brain or nerve involvement. Infusions can cause reactions, including rare life-threatening allergic reactions, so they are given where medical monitoring is available. Starting or increasing the dose during pregnancy is not recommended, so pregnancy plans and contraception are part of the discussion. Supportive care addresses specific problems. This can include vaccines against flu, COVID-19 and pneumococcal pneumonia, oxygen for advanced lung disease, monitoring for liver scarring, a hematologist's help with significant bleeding, attention to bone health and nutrition, and an individualized decision about cholesterol-lowering medicine. Removing the spleen is generally avoided because it can make liver and lung disease worse; partial procedures are reserved for rare severe cases.
Type B is a lifelong condition with a very wide range of outcomes. Some people stay stable for years with few symptoms; others have progressive lung or liver disease, which are the main causes of serious illness in type B. Many people live well into adulthood, and some have a normal lifespan. Children are often shorter and lighter than their peers, and puberty may come late, but most reach an adult height in the low normal range. Daily life can involve tiredness, chronic pain, shortness of breath with exertion and easy bruising. An enlarged spleen can rupture, so contact sports are best avoided. Anxiety, depression and social isolation are more common, and psychological support is part of good care. Regular follow-up usually includes checks of spleen and liver size, lung function, blood counts, liver tests and cholesterol, plus neurological review. People on enzyme replacement have infusions every two weeks over the long term. Teenagers benefit from a planned move from pediatric to adult metabolic care, and adults planning a family may want genetic counseling.
Ask about testing for this condition if an enlarged spleen or liver, a low platelet count or unexplained lung changes have not been explained, or if a relative has been diagnosed. Contact the care team promptly about a cough with fever, breathing that is getting worse, frequent nosebleeds or new yellowing of the skin or eyes. Seek emergency care for sudden severe belly pain, especially after a blow or fall, for vomiting blood, or for bleeding that will not stop.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Niemann-Pick Disease Type B is like, what's helped you, or ask the community a question.